Chronic fatigue syndrome eased by cancer drug New Scientist Symptoms of the disease eased in 10 of 15 patients given rituximab, an anti-lymphoma drug. Rituximab works by destroying white blood cells that make antibodies, called B cells. The results of the trial therefore strongly suggest that these white blood ... B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic ... |
